Literature DB >> 7601558

Menstrual and reproductive factors and pancreatic cancer risk in women.

E Fernandez1, C La Vecchia, B D'Avanzo, E Negri.   

Abstract

To investigate possible correlates of the systematically higher pancreatic cancer rates in males than in females, the role of menstrual, reproductive and hormonal factors in females have been assessed using data from a case-control study conducted in Northern Italy. Cases were 133 women with histologically confirmed incident cancer of the pancreas, and controls were 377 women in hospital for acute, non-neoplastic, non-digestive-tract disorders. After allowance for age, education, area of residence and smoking habit, an increased risk of pancreatic cancer was observed in women with early menarche (< or = 13 years) (OR = 1.9; 95% CI: 1.0-3.6), but no significant association was observed with age at menopause or length of fertile life. Parous women were at reduced risk as compared to nulliparous women (OR = 0.7), although the trend in risk with number of births was not significant. No association with spontaneous or induced abortions was observed. Pancreatic cancer risk was inversely related to early age at first birth (first birth < 25 versus nulliparae: OR = 0.5; 95% CI: 0.3-0.9; p-value for trend < 0.01) and to age at last birth (last birth < 25 versus nulliparae: OR = 0.3; 95% CI: 0.1-0.8; p-value for trend < 0.05). Ever-users of estrogen replacement therapy showed a non-significantly increased risk (OR = 2.2). Although no clear pattern of association is evident, the present results are in agreement with previous epidemiological observations and experimental research indicating that hormonal (menstrual and reproductive) factors could explain part of the male-to-female differential in incidence and mortality from pancreatic cancer.

Entities:  

Mesh:

Year:  1995        PMID: 7601558     DOI: 10.1002/ijc.2910620104

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  17 in total

Review 1.  Chemoprevention for pancreatic cancer.

Authors:  Robert A Wolff
Journal:  Int J Gastrointest Cancer       Date:  2003

2.  Association of menstrual and reproductive factors with pancreatic cancer risk in women: findings of the Japan Collaborative Cohort Study for Evaluation of Cancer Risk.

Authors:  Yingsong Lin; Shogo Kikuchi; Akiko Tamakoshi; Takashi Kawamura; Yutaka Inaba; Michiko Kurosawa; Yutaka Motohashi; Kiyoko Yagyu; Yuki Obata; Teruo Ishibashi
Journal:  J Gastroenterol       Date:  2006-09       Impact factor: 7.527

3.  Reproductive factors, exogenous hormones, and pancreatic cancer risk in the CTS.

Authors:  Eunjung Lee; Pamela L Horn-Ross; Rudolph P Rull; Susan L Neuhausen; Hoda Anton-Culver; Giske Ursin; Katherine D Henderson; Leslie Bernstein
Journal:  Am J Epidemiol       Date:  2013-09-05       Impact factor: 4.897

4.  Menstrual and Reproductive Factors, Hormone Use, and Risk of Pancreatic Cancer: Analysis From the International Pancreatic Cancer Case-Control Consortium (PanC4).

Authors:  Leila Lujan-Barroso; Wei Zhang; Sara H Olson; Yu-Tang Gao; Herbert Yu; Peter A Baghurst; Paige M Bracci; H Bas Bueno-de-Mesquita; Lenka Foretová; Steven Gallinger; Ivana Holcatova; Vladimír Janout; Bu-Tian Ji; Robert C Kurtz; Carlo La Vecchia; Pagona Lagiou; Donghui Li; Anthony B Miller; Diego Serraino; Witold Zatonski; Harvey A Risch; Eric J Duell
Journal:  Pancreas       Date:  2016-11       Impact factor: 3.327

5.  A case-control study of reproductive factors, female hormone use, and risk of pancreatic cancer.

Authors:  Yuqing Zhang; Patricia F Coogan; Julie R Palmer; Brian L Strom; Lynn Rosenberg
Journal:  Cancer Causes Control       Date:  2009-11-26       Impact factor: 2.506

6.  Reproductive history and pancreatic cancer incidence and mortality in a cohort of postmenopausal women.

Authors:  Richard J Stevens; Andrew W Roddam; Jane Green; Kirstin Pirie; Diana Bull; Gillian K Reeves; Valerie Beral
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-05       Impact factor: 4.254

7.  Genetic variation in CYP17A1 and pancreatic cancer in a population-based case-control study in the San Francisco Bay Area, California.

Authors:  Eric J Duell; Elizabeth A Holly; Karl T Kelsey; Paige M Bracci
Journal:  Int J Cancer       Date:  2010-02-01       Impact factor: 7.396

8.  Menopausal hormone therapy and pancreatic cancer risk in women: a population-based matched cohort study.

Authors:  Omid Sadr-Azodi; Peter Konings; Nele Brusselaers
Journal:  United European Gastroenterol J       Date:  2017-04-09       Impact factor: 4.623

9.  Role of vitamin d in the prevention of pancreatic cancer.

Authors:  Pubudu Bulathsinghala; Kostas N Syrigos; Muhammad W Saif
Journal:  J Nutr Metab       Date:  2011-01-09

10.  Reproductive factors and pancreatic cancer risk: a Norwegian cohort study.

Authors:  I Heuch; B K Jacobsen; G Albrektsen; G Kvåle
Journal:  Br J Cancer       Date:  2007-11-13       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.